Nursing Events

NCCN 2024 Nursing Program: Advancing Oncology Nursing™ Thursday, April 4, 2024 Orlando World Center Marriott, Orlando, FL | Virtual attendance also available Nurses are invited to attend the NCCN 2024 Annual Congress: Hematologic Malignancies™ Friday, September 20, 2024 – Saturday, September 21, 2024 New York Marri ott Marquis, New York, NY | Virtual attendance also available Access presentations from the NCCN 2023 Nursing Program: Advancing Oncology Nursing™ on the NCCN Continuing Education

Read the full article here

Source: www.nccn.org

Categories: Onc News and Journals, General Medicine News

Tweets with this article

National Comprehensive Cancer Network (NCCN)

Join us in Orlando for the NCCN 2024 Nursing Program: Advancing Oncology Nursing™. Attendees can gain practical knowledge from leading clinical nursing experts and attend a special networking reception. Register now: https://t.co/8u8Ox0Kg8j https://t.co/3F32xkfv0L

Related Articles

FDA Approves Toripalimab for Advanced Nasopharyngeal Cancer

Adding toripalimab (Loqtorzi) to chemo extended survival in people with nasopharyngeal cancer that returned after initial treatment or spread in the body.

National Cancer Institute December 30, 2024

The OncoAlert Newsletter is NOW OUT Click to Register

The OncoAlert Newsletter is now out for June 23-29, 2023

OncoAlert December 30, 2024

BSH Abstract Submission | Haematology Abstracts

Submitting an abstract for BSH2023 will provide you with the opportunity to promote your research to a wide audience of haematology professionals.

BSH - Haematology December 30, 2024

Collection Details : Oncology Times

Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care

Oncology Times December 30, 2024

Prostate Cancer Patients Receiving ADT May Not Undergo Appropriate Monitoring – Oncology Nurse Advisor

More research is needed to address barriers to therapeutic monitoring of prostate cancer patients on androgen deprivation therapy, according to researchers.

OncologyNurseAdvisor December 30, 2024

FDA Broad Agency Announcement: Frequently Asked Questions for Oncology

FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers

FDA Oncology December 29, 2024

National Cancer Plan – Join Us

The National Cancer Plan provides a comprehensive framework for meaningful collaboration to change how we know cancer today.

National Cancer Institute December 29, 2024

BRAF-Targeted Drug Approved for Pediatric Low-Grade Glioma

FDA has granted an accelerated approval to tovorafenib (Ojemda) for kids and teens who have low-grade glioma with changes in the BRAF gene.

National Cancer Institute December 29, 2024

Cancer Drug Access and Innovation Under the Inflation Reduction Act

This Viewpoint explores whether the Inflation Reduction Act’s provisions and price negotiations could affect investment in trials of new oncology therapies or indications.

JAMA Oncology December 29, 2024

Real-World Treatment Patterns and Economic Burden of Marginal Zone Lymphoma | Blood Cancers Today

A retrospective study analyzed treatment trends and associated health care costs for patients with MZL using Optum’s de-identified Clinformatics® Data Mart Database.

Blood Cancers Today December 28, 2024